SCF <sup>FBXO22</sup> targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis
Jin Bai(Xuzhou Medical College), Zhen‐Qiang Pan(Icahn School of Medicine at Mount Sinai), Kenneth Wu(Icahn School of Medicine at Mount Sinai), Menghan Cao(Xuzhou Medical College), Yoko Itahana(Duke-NUS Medical School), Junnian Zheng(Xuzhou Medical College), Lan Huang(University of California, Irvine), Hui Liu(Shanghai University), Yizhou He(University of North Carolina at Chapel Hill), Yingying Yang(Kunming Medical University), Yu Pan(Fujian Medical University)
Cited by 61
Related Papers
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
|Journal of Clinical Oncology|2018|976
The cullin protein family
|Genome Biology|2011|512
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|Journal of Clinical Oncology|2015|418
LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification
|Journal of Experimental & Clinical Cancer Research|2021|292
ATM and Chk2‐dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
|The EMBO Journal|2005|256